Tempus AI TEM has skyrocketed 21% in the last three days, fueled by news of a $200 million partnership with AstraZeneca AZN ...

Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report ...

Tempus AI expands deals with AstraZeneca and Pathos for $200M, Avidicure raises $50M seed round, Bioxodes reports Phase 2a ...

Before we get into Thursday’s column, be sure to read my colleague Sri’s story on OpenAI’s revenue forecasts. The projections ...

Medical Properties Trust, Inc. today announced it will host a conference call and webcast on Thursday, May 1, 2025 at 11:00 a.m. Eastern Time to discuss the company's first quarter 2025 financial ...

Berger Montague PC advises investors that a securities class action lawsuit has been filed against BigBear.ai Holdings, Inc. ("BigBear" or the "Company") on behalf of purchasers of BigBear securities ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $63.78, ...

Tempus AI (TEM) has seen a significant surge on Wednesday, with its stock climbing 14.62% in just one day. The significant boost in TEM stock ...

With the stock market in rally mode, there are more pockets of strength than there have been in a while. Among the winners ...

Many of America’s wealthiest business leaders have lost millions — if not billions — of dollars in net worth since the start of the year, as President Donald Trump’s policies hit markets. But some ...

Amid a bullish backdrop for the broader market, Tempus AI (NASDAQ: TEM) stock is posting big gains Wednesday. The company's ...

Tempus AI Inc (NASDAQ:TEM) shares are surging Wednesday after the company announced a multi-year collaboration with ...